Comparison of effects of albendazole sulfoxide on in vitro produced bovine embryos and rat embryos.
OBJECTIVE
To evaluate and compare effects of albendazole sulfoxide (ABZSO) on rat embryos and bovine embryos produced in vitro.


METHODS
In vitro produced bovine embryos. Rat embryos recovered from naturally bred Sprague-Dawley rats.


METHODS
4- and 8-cell bovine embryos were randomly allocated to ABZSO or vehicle control groups. After 48 hours, embryos were evaluated for cell number and blastomere morphology. Rat embryos of similar stages, flushed from the uterine tube on gestational day 2-5, were randomly allocated to treatment or control groups. After 24 hours, embryos were evaluated as described previously.


RESULTS
44% of control bovine embryos divided in culture (> or = 16-cell stage). Fifteen percent of the controls had morphologic abnormalities, including disparity in blastomere size and cytoplasmic vacuoles and stippling. Treated (> or = 1 microgram of ABZSO/ml) bovine embryos differed (P < 0.0001) from controls, with 4% development and 93% abnormal morphology. Forty-five percent of control rat embryos divided in culture. Treated (> or = 500 ng of ABZSO/ml) rat embryos differed (P < 0.0003) from controls with regard to ability to divide. There were no consistent morphologic abnormalities in rat embryos.


CONCLUSIONS
In vitro produced bovine embryos were susceptible to ABZSO at a concentration > or = 1 microgram/ ml, resulting in decreased ability to divide and presence of gross morphologic abnormalities. Rat embryos produced in vivo and exposed in vitro to ABZSO at a concentration > or = 500 ng/ml had decreased ability to divide in culture.


CONCLUSIONS
Despite severe effects of ABZSO (> or = 1 microgram/ml) on bovine embryo development in vitro, it is beyond the scope of this study to speculate whether a therapeutic dosage of albendazole (10 mg/kg of body weight) would result in necessary concentrations of ABZSO in vivo to disrupt embryogenesis.
Piscopo
S E
SE
Department of Animal Science, College of Veterinary Medicine, North Carolina State University, Raleigh 27606, USA.
Smoak
I W
IW
D000014:Abnormalities, Drug-Induced; D015766:Albendazole / Q000031:analogs & derivatives* / Q000494:pharmacology; D000818:Animals; D000871:Anthelmintics / Q000494:pharmacology*; D001757:Blastomeres / Q000166:cytology / Q000187:drug effects / Q000502:physiology*; D002417:Cattle; D002455:Cell Division; D004622:Embryo, Mammalian / Q000166:cytology / Q000187:drug effects / Q000502:physiology*; D005314:Embryonic and Fetal Development / Q000187:drug effects; D005260:Female; D005306:Fertilization; D005307:Fertilization in Vitro; D005865:Gestational Age; D008297:Male; D009028:Morula / Q000166:cytology / Q000187:drug effects / Q000502:physiology; D051381:Rats; D017207:Rats, Sprague-Dawley
D000871:Anthelmintics; D015766:Albendazole; C027186:albendazole sulfoxide